Bank of America
DWTX

Bank of America’s Dogwood Therapeutics DWTX Stock Holding History

Bank of America’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,415
Closed -$39.2K – 7095
2025
Q4 		$39.2K Buy
9,415
+9,399
+58,744% +$55.3K ﹤0.01% 5907
2025
Q3 		$123 Sell
16
-1
-6% -$5 ﹤0.01% 7815
2025
Q2 		$81 Buy
17
+7
+70% +$34 ﹤0.01% 8004
2025
Q1 		$50 Hold
10
– – ﹤0.01% 7985
2024
Q4 		$25 Buy
10
+2
+25% +$7 ﹤0.01% 7991
2024
Q3 		$36 Buy
8
+2
+33% +$10 ﹤0.01% 7883
2024
Q2 		$30 Buy
+6
New +$52 ﹤0.01% 7936
2022
Q1 		– Hold
0
– – – 8865
2021
Q4 		– Hold
0
– – – 8719

Other funds holding DWTX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Bank of America's DWTX Position: Q1 2026 in Review

Bank of America sold out of Dogwood Therapeutics (DWTX) in Q1 2026, closing a stake of 9,415 shares — an estimated $39.2K sold.

Bank of America first reported a position in DWTX in Q2 2024 and held it in 7 quarters. The position peaked at $39.2K in Q4 2025. 13 funds tracked by Wall St. Rank hold DWTX as of Q1 2026.

  • Bank of America reported no remaining Dogwood Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 9,415 Dogwood Therapeutics shares in Q1 2026, an estimated $39.2K.
  • Bank of America first reported a position in Dogwood Therapeutics in Q2 2024 and held it in 7 quarters.
  • Bank of America's Dogwood Therapeutics position peaked at $39.2K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.